Infectious Diseases (except HIV/AIDS)

Analysis and Applications of Adaptive Group Testing Methods for COVID-19
Cassidy Mentus, Martin Romeo, Christian DiPaola

medRxiv 2020.04.05.20050245; doi: https://doi.org/10.1101/2020.04.05.20050245

Add to Selected Citations
Isolation and contact tracing can tip the scale to containment of COVID-19 in populations with social distancing
Mirjam E. Kretzschmar, Ganna Rozhnova, Michiel van Boven

medRxiv 2020.03.10.20033738; doi: https://doi.org/10.1101/2020.03.10.20033738

Add to Selected Citations
Introductions and early spread of SARS-CoV-2 in the New York City area
Ana S. Gonzalez-Reiche, Matthew M. Hernandez, Mitchell Sullivan, Brianne Ciferri, Hala Alshammary, Ajay Obla, Shelcie Fabre, Giulio Kleiner, Jose Polanco, Zenab Khan, Bremy Alburquerque, Adriana van de Guchte, Jayeeta Dutta, Nancy Francoeur, Betsaida Salom Melo, Irina Oussenko, Gintaras Deikus, Juan Soto, Shwetha Hara Sridhar, Ying-Chih Wang, Kathryn Twyman, Andrew Kasarskis, Deena Rose Altman, Melissa Smith, Robert Sebra, Judith Aberg, Florian Krammer, Adolfo García-Sastre, Marta Luksza, Gopi Patel, Alberto Paniz-Mondolfi, Melissa Gitman, Emilia Mia Sordillo, Viviana Simon, Harm van Bakel

medRxiv 2020.04.08.20056929; doi: https://doi.org/10.1101/2020.04.08.20056929

Add to Selected Citations
COVID-19-related mortality by age groups in Europe: A meta-analysis
Jérémie F. Cohen, Daniël A. Korevaar, Soraya Matczak, Joséphine Brice, Martin Chalumeau, Julie Toubiana

medRxiv 2020.04.11.20061721; doi: https://doi.org/10.1101/2020.04.11.20061721

Add to Selected Citations
Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio Emilia, Italy
Paolo Giorgi Rossi, Massimiliano Marino, Debora Formisano, Francesco Venturelli, Massimo Vicentini, Roberto Grilli, the Reggio Emilia COVID-19 Working Group

medRxiv 2020.04.13.20063545; doi: https://doi.org/10.1101/2020.04.13.20063545

Add to Selected Citations
An exploratory randomized controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI)
Yueping Li, Zhiwei Xie, Weiyin Lin, Weiping Cai, Chunyan Wen, Yujuan Guan, Xiaoneng Mo, Jian Wang, Yaping Wang, Ping Peng, Xudan Chen, Wenxin Hong, Guangming Xiao, Jinxin Liu, Lieguang Zhang, Fengyu Hu, Feng Li, Fuchun Zhang, Xilong Deng, Linghua Li

medRxiv 2020.03.19.20038984; doi: https://doi.org/10.1101/2020.03.19.20038984

Add to Selected Citations
COVID-19 is an emergent disease of aging
Didac Santesmasses, José Pedro Castro, Aleksandr A. Zenin, Anastasia V. Shindyapina, Maxim V. Gerashchenko, Bohan Zhang, Csaba Kerepesi, Sun Hee Yim, Peter O. Fedichev, Vadim N. Gladyshev

medRxiv 2020.04.15.20060095; doi: https://doi.org/10.1101/2020.04.15.20060095

Add to Selected Citations
Separate Fever Clinics Prevent the Spread of COVID-19 and Offload Emergency Resources: Analysis from a large tertiary hospital in China
Jiangshan Wang, Liang Zong, Jinghong Zhang, Han Sun, Joseph Harold Walline, Pengxia Sun, Shengyong Xu, Yan Li, Chunting Wang, Jihai Liu, Fan Li, Jun Xu, Yi Li, Xuezhong Yu, Huadong Zhu

medRxiv 2020.04.03.20051813; doi: https://doi.org/10.1101/2020.04.03.20051813

Add to Selected Citations
Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial
Chang Chen, Yi Zhang, Jianying Huang, Ping Yin, Zhenshun Cheng, Jianyuan Wu, Song Chen, Yongxi Zhang, Bo Chen, Mengxin Lu, Yongwen Luo, Lingao Ju, Jingyi Zhang, Xinghuan Wang

medRxiv 2020.03.17.20037432; doi: https://doi.org/10.1101/2020.03.17.20037432

Add to Selected Citations
Assessing the impact of a symptom-based mass screening and testing intervention during a novel infectious disease outbreak: The case of COVID-19
Yang Ge, Brian Kenneth McKay, Shengzhi Sun, Feng Zhang, Andreas Handel

medRxiv 2020.02.20.20025973; doi: https://doi.org/10.1101/2020.02.20.20025973

Add to Selected Citations

Infectious Diseases (except HIV/AIDS)

Pages